Contamination Concerns Raise Questions About Pharmaceutical Oversight The recent recall of certain Pregabalin capsules by Teva Canada due to possible sertraline contamination highlights the need for stricter quality control measures in the pharmaceutical industry.
The affected products, sold as part of routine treatment for nerve damage pain relief, have now been identified as potential carriers of a substance that can trigger severe allergic reactions.
Health Canada has issued a recall notice warning patients with hypersensitivities or allergies to sertraline that exposure could lead to anaphylactic reactions, which in extreme cases can be fatal.